{
    "clinical_study": {
        "@rank": "8041", 
        "acronym": "ProShort-Ped", 
        "arm_group": [
            {
                "arm_group_label": "Procalcitonin-guided treatment", 
                "arm_group_type": "Experimental", 
                "description": "The duration of antibiotics will be determined by the procalcitonin levels."
            }, 
            {
                "arm_group_label": "Conventional treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "The duration of antibiotics will be determined by the treating physician."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to give conclusive evidence on whether serial PCT\n      (Procalcitonin) measurements can facilitate individual decision-making and shorten\n      antibiotic treatment duration in patients with sepsis in the pediatric ICU (Intensive Care\n      Unit)."
        }, 
        "brief_title": "PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) Trial", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Sepsis", 
        "condition_browse": {
            "mesh_term": "Sepsis"
        }, 
        "detailed_description": {
            "textblock": "In this study, the investigators aimed to design a multi-center trial addressing\n      aforementioned flaws. The investigators will set stricter inclusion criteria, collect\n      complete data on relapse or secondary infection, and include sufficient number of patients\n      to show non-inferiority to conventional therapy by a delta margin of 10% [11]. The\n      investigators aimed to give conclusive evidence on whether serial PCT measurements can\n      facilitate individual decision-making and shorten antibiotic treatment duration in patients\n      with sepsis in the pediatric ICU."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        All patients with laboratory- or image-confirmed severe infection at admission or during\n        stay in pediatric ICU will be eligible for inclusion.\n\n        * Definition of laboratory- or image-confirmed severe infection:\n\n          -  Two or more of four signs of inflammation:\n\n               -  Temperature >38.3\u2103 or <36\u2103\n\n               -  Heart rate > 90 beats/min\n\n               -  Respiratory rate >20 breaths/min or PaCO2 (Arterial pressure of carbon dioxide)\n                  < 32 mmHg\n\n               -  WBC (White Blood Cell count) > 12,000 cells/mm3, <4000 cells/mm3, or >5%\n                  band-form WBC\n\n          -  Initial Procalcitonin > 0.5 ng/mL\n\n          -  Presence of either laboratory or image evidence of infection\n\n          -  Laboratory evidence: Sign of inflammation in urine, CSF (Cerebrospinal Fluid),\n             ascites, pleural effusion or local abscess\n\n          -  Image evidence: Compatible findings on Chest X ray, ultrasound, CT (Computed\n             Tomography), MR image (Magnetic Resonance Image)\n\n        Exclusion Criteria:\n\n          -  Age greater than 15 years or less than 1 month\n\n          -  Known pregnancy\n\n          -  Expected ICU stay less than 3 days\n\n          -  Neutropenia: ANC (Absolute Neutrophil Count) <500/mm3\n\n          -  Specific infections for which long-term antibiotic treatment is strongly recommended:\n\n               -  Lobar pneumonia or empyema\n\n               -  Bacterial meningitis\n\n               -  Osteomyelitis\n\n               -  Infective endocarditis\n\n               -  Local abscess\n\n               -  Mediastinitin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "15 Years", 
            "minimum_age": "1 Month"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 22, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01652404", 
            "org_study_id": "HN01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Procalcitonin-guided treatment", 
                "description": "The antibiotics duration will be determined by the serum procalcitonin level at day 5, 7 and 9.", 
                "intervention_name": "Procalcitonin-guided treatment", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Conventional treatment", 
                "description": "The antibiotics duration will be determined by treating physician.", 
                "intervention_name": "Conventional treatment", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ICU", 
            "sepsis", 
            "antibiotic therapy", 
            "procalcitonin"
        ], 
        "lastchanged_date": "July 27, 2012", 
        "location": {
            "contact": {
                "email": "csvzhuyimin@163.com", 
                "last_name": "Yi-Min Zhu, BSc", 
                "phone": "073185386850"
            }, 
            "facility": {
                "address": {
                    "city": "Changsha", 
                    "country": "China", 
                    "state": "Hunan"
                }, 
                "name": "Hunan Children's Hospital"
            }, 
            "investigator": {
                "last_name": "Yi-Min Zhu, BSc", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "PROcalcitonin to SHORTen Antibiotics Duration in PEDiatricICU Patients (ProShort-Ped) Trial", 
        "overall_contact": {
            "email": "cclee100@gmail.com", 
            "last_name": "Chien-Chang Lee, MD, MSc", 
            "phone": "886972651951"
        }, 
        "overall_contact_backup": {
            "email": "csvzhuyimin@163.com", 
            "last_name": "Yi-Min Zhu, BSc", 
            "phone": "073185356850"
        }, 
        "overall_official": [
            {
                "affiliation": "National Taiwan University Hospital", 
                "last_name": "Chien-Chang Lee, MD, MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hunan Children's Hospital", 
                "last_name": "Yi-Min Zhu, BSc", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Efficacy endpoint", 
                "measure": "Average antibiotics duration", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "description": "Safety endpoint", 
                "measure": "28-day mortality rate", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }
        ], 
        "reference": [
            {
                "PMID": "12535494", 
                "citation": "Michael M, Hodson EM, Craig JC, Martin S, Moyer VA. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev. 2003;(1):CD003966. Review."
            }, 
            {
                "PMID": "21034941", 
                "citation": "Lee SL, Islam S, Cassidy LD, Abdullah F, Arca MJ; 2010 American Pediatric Surgical Association Outcomes and Clinical Trials Committee. Antibiotics and appendicitis in the pediatric population: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2010 Nov;45(11):2181-5. doi: 10.1016/j.jpedsurg.2010.06.038. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01652404"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Efficacy endpoint", 
                "measure": "Proportion of antibiotics use in both arms", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "description": "Efficacy endpoint", 
                "measure": "Length of ICU stay", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Safety endpoint", 
                "measure": "Recurrence of fever within 72 hours of antibiotics discontinuation", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }, 
            {
                "description": "Safety endpoint", 
                "measure": "SOFA score (Sequential Organ Failure Assessment score)", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }, 
            {
                "description": "Safety endpoint", 
                "measure": "Reinfection rate between 72-hours and 28 days post antibiotics discontinuation", 
                "safety_issue": "Yes", 
                "time_frame": "28 days"
            }, 
            {
                "description": "Safety endpoint", 
                "measure": "90-day all-cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }, 
            {
                "description": "Safety endpoint", 
                "measure": "90-day readmission rate", 
                "safety_issue": "Yes", 
                "time_frame": "90 days"
            }
        ], 
        "source": "Hunan Children's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Hunan Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }
}